EDE has issued Pharmacovigilance Practice Guideline for Medical Products
According to Resolution No. (27) of 2026, published by the Emirates Drug
Regulinked
- July 29, 2026
- Acceleration process
- No Comments
Tag: Regulinked
SFDA has issued Regulatory Guide for SFDA Services in Duty- and Tax-Suspended Zones
SFDA has issued a new regulatory guide clarifying the services and requirements
- July 28, 2026
- Acceleration process
- No Comments
SFDA published six guidelines regarding classification of violations and associated penalties
SFDA has published six guidelines regarding classification of violations and associated penalties
- July 28, 2026
- Acceleration process
- No Comments
Oman MOH – Circular No. Circular No. 51/2026 – Suspension of Receiving Medicines and Biological Products Registration Files
OMAN MOH issued new Circular No. 51/2026 – Suspension of Receiving Medicines
- May 31, 2026
- Guideline
- No Comments
Oman MOH – Circular No. 45/2026 – Adherence to Procuring Medicines and Health Products from Authorized Agents Only
OMAN MOH issued new Circular No. 45/2026 – Adherence to Procuring Medicines
- April 30, 2026
- Guideline
- No Comments
Oman MOH – Circular No. 35/2026 introducing updated restrictions on the use of Ivy Leaf Extract in herbal medicines
OMAN MOH issued new Circular No. 35/2026 introducing updated restrictions on the
- April 10, 2026
- Guideline
- No Comments
SFDA Issues “Guidelines for Chemical and Pharmaceutical Quality Documentation of Small Molecules Investigational Products in Clinical Trials” (Version 1.0)
Saudi Food and Drug Authority (SFDA) has issued Version 1.0 of new
- March 21, 2026
- Acceleration process
- No Comments
SFDA Issues Updated Guidance on “Combination Products Classification and Registration” (Version 2.0)
SFDA has issued Version 2.0 of the “Guidance for Combination Products Classification
- March 15, 2026
- Acceleration process
- No Comments
SFDA – “Products Classification Guidance” V 9.0
SFDA has issued Version 9.0 of the “Products Classification Guidance”, introducing updated
- February 12, 2026
- Acceleration process
- No Comments
SFDA- “Clinical Considerations for Vaccines” V 2.0
SFDA issued the updated “Clinical Considerations for Vaccines” guideline – Version 2.0
- February 12, 2026
- Acceleration process
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.